1331 TYLER STREET NE STE 200, MINNEAPOLIS, MN
Reports Second Quarter 2026 Financial Results
Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients
Stockholders Approve Amendment for Director Removal Procedures
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Strengthens Board of Directors with Appointment of Andrea Pearson
Reports Fourth Quarter and Full Year 2025 Financial Results, Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio
Earnings Release
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
Correspondence